Atlas Trials

Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer

Clinical trial NCT04149613 · UNKNOWN

Trial details

NCT number
NCT04149613
Sponsor
American University of Beirut Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Colorectal Cancer Stage IV
Start date
2018-05-25
Primary completion
2025-07-15
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.